Proteomic Signature of Frailty Pace Reflects Biological Aging and Predicts Disease and Mortality

Abstract

Frailty is a clinical manifestation of aging characterized by reduced physiological resilience and increased vulnerability to adverse outcomes. Plasma proteomics offers potential for tracking biological aging, yet few studies have used it to quantify frailty progression over time.